Graf Acquisition
Why Robinhood?
You can watch GFOR and buy or sell other stocks, ETFs, and their options commission-free!About GFOR
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.
GFOR Key Statistics
Stock Snapshot
The current Graf Acquisition(GFOR) stock price is $0.01, with a market capitalization of 1.31M.
During the trading day, Graf Acquisition(GFOR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Graf Acquisition(GFOR) stock has reached 0, versus its average volume of 2.34K.
Over the past 52 weeks, Graf Acquisition(GFOR) stock has traded between a high of $0.20 and a low of $0.00.
Over the past 52 weeks, Graf Acquisition(GFOR) stock has traded between a high of $0.20 and a low of $0.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.